GlassScriptPhysician profile
Dennis L Clark
NPI 1699700849
$8,716.24
in general payments reported to CMS, 2019-2025
44 companies · $945 in 2025
The $945 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2020: $1,352 · 2021: $1,786 · 2022: $1,000 · 2023: $1,351 · 2024: $1,093 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,388.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,073.80 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $1,009.62 | 2019-2025 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $765.32 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $744.90 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $649.47 | 2019-2023 | Xifaxan |
| Gilead Sciences, INC. | $539.85 | 2019-2022 | |
| Lilly USA, LLC | $526.17 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $384.05 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $316.07 | 2019-2023 | Xarelto |
| Amarin Pharma, INC. | $287.86 | 2019-2021 | |
| Eisai INC. | $261.80 | 2020-2022 | |
| Glaxosmithkline, LLC. | $168.61 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $154.40 | 2019-2020 | |
| Exact Sciences Corporation | $153.79 | 2023-2025 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $149.34 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.